Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Fortress Biotech (FBIO) Short-Term Debt repayments (2022 - 2024)

Historic Short-Term Debt repayments for Fortress Biotech (FBIO) over the last 4 years, with Q4 2024 value amounting to $5.0 million.

  • Fortress Biotech's Short-Term Debt repayments fell 6580.03% to $5.0 million in Q4 2024 from the same period last year, while for Sep 2025 it was $19.6 million, marking a year-over-year increase of 3432.63%. This contributed to the annual value of $10.0 million for FY2024, which is 3151.63% down from last year.
  • Fortress Biotech's Short-Term Debt repayments amounted to $5.0 million in Q4 2024, which was down 6580.03% from -$50000.0 recorded in Q3 2024.
  • In the past 5 years, Fortress Biotech's Short-Term Debt repayments ranged from a high of $14.6 million in Q4 2023 and a low of -$50000.0 during Q3 2024
  • For the 3-year period, Fortress Biotech's Short-Term Debt repayments averaged around $4.9 million, with its median value being $5.0 million (2022).
  • The largest annual percentage gain for Fortress Biotech's Short-Term Debt repayments in the last 5 years was 6580.03% (2024), contrasted with its biggest fall of 490000.0% (2024).
  • Fortress Biotech's Short-Term Debt repayments (Quarter) stood at $5.0 million in 2022, then surged by 192.4% to $14.6 million in 2023, then plummeted by 65.8% to $5.0 million in 2024.
  • Its Short-Term Debt repayments stands at $5.0 million for Q4 2024, versus -$50000.0 for Q3 2024 and $14.6 million for Q4 2023.